Profile

Quest is an Alberta-based biotechnology company developing a portfolio of product candidates for the treatment of cancer by combining immunotherapeutic antibodies with chemotherapy, photodynamic therapy, radioimmunotherapy or immunoadjuvants.

Overview

Quest is positioned as a drug development company focused on novel therapies for the treatment of cancer.

• Maximize growth by concentrating resources on drug development and extracting value to support this activity through strategic partners.

• Reduce risk by acquiring products or technologies that are close to attaining, or have already attained, clinical status.

• Participate in high-growth markets, focus on diseases with unmet treatment needs or near-to-market potential.

• Develop proprietary, unique multi-tiered approach to the treatment of cancer.